Fresenius Medical Care shares tumble as cautious 2026 outlook offsets strong profit growth
The German dialysis provider reported a sharp rise in fourth-quarter profit but warned of flat sales for 2026. Shares fell as investors reacted to headwinds.
Insights:
Fresenius Medical Care AG & Co. KGaA saw its shares fall by approximately 10% at the market open today, February 24, 2026, after the company issued a cautious financial outlook for 2026. The guidance, which was released contemporaneously with strong fourth-quarter results, projects that sales will remain level with 2025. Additionally, the company expects adjusted operating income for 2026 to be between a mid-single-digit percent decline and a mid-single-digit percent increase, a forecast that immediately altered near-term investor expectations.
